生物資訊學：科技與全球市場

全球生物資訊市場預計到 2025 年將達到 235 億美元，預計從 2025 年到 2030 年將以 13.1% 的複合年成長率成長，到 2030 年底將達到 435 億美元。

調查範圍

本報告概述了全球生物資訊學市場並分析了市場趨勢。報告包含2024年基準年的全球銷售額（百萬美元）以及2025年至2030年預測期間的銷售額預估值。市場按解決方案、定序服務和平台、部署模式、應用程式、最終用戶和地區進行細分。本研究涵蓋北美、歐洲、亞太地區以及世界其他地區，並聚焦於各區域內的主要國家。

本報告重點在於影響市場和供應商格局的關鍵趨勢和挑戰，並探討與市場相關的新興技術。

該報告最後對競爭格局進行了分析，包括全球生物資訊學市場主要參與者的排名和市場佔有率數據。報告還特別闢出一節介紹公司概況，內容涵蓋公司概述、關鍵財務資訊、產品系列、主要市場參與者的最新發展以及專利分析等詳細資訊。

報告內容

• 數據表 68 和附加表 63
• 對全球生物資訊技術市場進行詳細分析
• 全球趨勢分析，包括 2022 年至 2024 年的歷史銷售數據、2025 年的估計值以及到 2030 年的複合年成長率預測。
• 目前市場規模估算和收入預測，以及基於解決方案、定序服務和平台、部署模型、應用、最終用途和地區的相應市場佔有率分析。
• 有關市場動態、技術進步、法規、前景和宏觀經濟變數的影響的事實和數據。
• 基於波特五力模型和全球供應鏈分析的見解。
• 審查主要專利的註冊和公佈狀態
• 產業結構分析，包括企業市場占有率分析、全球排名、策略舉措、併購活動和創業融資前景。
• 概述永續發展趨勢和ESG進展。重點關注消費者意識以及主要公司的ESG風險評估和舉措。
• 業界領先公司的公司簡介，包括 Illumina Inc.、Thermo Fisher Scientific Inc.、Agilent Technologies Inc.、Bio-Rad Laboratories Inc. 和 PacBio。

目錄

第1章：摘要整理

第2章 市場概覽

• 介紹
• 目前及未來市場概覽
• 技術背景
• 生物資料來源
• 系統生物學中的生物資訊學
• 精準醫學中的生物資訊學
• 生物資訊學在藥物發現的應用
• 次世代定序
• 總體基因體學中的生物資訊學
• 資料庫管理系統中的生物資訊學
• PESTLE分析
• 美國關稅法對全球生物資訊市場的影響
• 波特五力分析
• 供應鏈分析
• 上游工程：資料產生與原始數據
• 技術基礎設施和平台的發展
• 資料處理、分析與解釋
• 中游整合與檢驗
• 下游產業：商業化與終端用戶
• 支持服務和生態系統合作夥伴
• 主要供應鏈的風險與限制因素
• 供應鏈最佳化趨勢
• 價值鏈分析
• 入境旅遊活動：數據和資訊收集
• 營運：平台和演算法開發
• 數據處理和分析服務
• 整合、檢驗和解釋
• 行銷、銷售和商業化
• 服務、支援和持續改進

第3章 市場動態

• 概述
• 市場促進因素
• 生物和基因組數據的指數級成長
• 個人化醫療和精準醫療的擴展
• 人工智慧、機器學習和進階分析的整合
• 雲端運算和可擴展平台
• 對藥物發現和開發工具的需求日益成長
• 市場限制因素
• 對資料隱私和安全的擔憂
• 與建模系統相關的挑戰
• 實施和維護成本高。
• 市場機遇
• 向新興國家拓展市場
• 次世代定序(NGS) 和高通量分析的發展

第4章 監管情勢

• 概述
• 法律規範（按國家/地區分類）
• 美國
• 歐洲
• 亞太地區
• 世界其他地區

第5章：新興科技與新趨勢

• 新興科技/趨勢
• 人工智慧（AI）與機器學習（ML）的融合
• 雲端運算和巨量資料基礎設施
• 高通量和先進的定序技術
• 多體學和單細胞分析
• 基因編輯資訊學
• 空間轉錄組學與影像技術的整合

第6章 市場區隔分析

• 細分市場
• 市場趨勢：按解決方案分類
• 硬體
• 軟體
• 服務
• 市場趨勢：依定序服務和平台分類
• 定序服務
• 定序平台
• 市場趨勢：按發展來看
• 現場
• 基於雲端的
• 市場趨勢：按應用領域分類
• 基因組學
• 蛋白質體學
• 轉錄組學
• 藥物基因體學
• 代謝體學
• 化學資訊學
• 總體基因體學
• 其他
• 市場趨勢：依最終用戶分類
• 製藥和生物技術公司
• 學術研究機構
• 其他
• 按地區分類
• 市場趨勢：按地區分類
• 北美洲
• 歐洲
• 亞太地區
• 世界其他地區（RoW）

第7章 競爭情勢

• 2024年主要公司排名
• 戰略分析

第8章附錄

• 調查方法
• 簡稱
• 參考
• 公司簡介
• AGILENT TECHNOLOGIES INC.
• BIO-RAD LABORATORIES INC.
• DASSAULT SYSTEMES
• DNASTAR
• EXCELRA
• ILLUMINA INC.
• MACVECTOR INC.
• MOLECULAR NETWORKS GMBH
• OCIMUM BIOSOLUTIONS
• PACBIO
• QLUCORE AB
• REAL TIME GENOMICS
• REVVITY
• SIEMENS HEALTHINEERS AG
• THERMO FISHER SCIENTIFIC INC.
• Emerging Start-Ups

The global bioinformatics market was valued at $23.5 billion in 2025 and is estimated to reach $43.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.1% from 2025 to 2030.

Report Scope

The report provides an overview of the global bioinformatics market and analyzes market trends. The report includes global revenue ($ million) for the base year, 2024, and estimated revenue for the forecast period, 2025 through 2030. The market is segmented by solution, sequencing services and platforms, deployment, application, end user, and region. The regions covered in this study include North America, Europe, Asia-Pacific, and the rest of the world, with a focus on major countries in each region.

The report focuses on the key driving trends and challenges shaping the market and vendor landscape. It discusses emerging technologies related to the market.

The report concludes with an analysis of the competitive landscape, which provides rankings and market shares for key companies in the global bioinformatics market. It also has a dedicated section of company profiles that covers details such as overviews, key financials, product portfolios, recent developments of key market companies, and patent analysis.

Report Includes

• 68 data tables and 63 additional tables
• In-depth analysis of the global market for bioinformatics technologies
• Analyses of the global market trends, with historic revenue data from 2022 to 2024, estimates for 2025 and projections of CAGRs through 2030
• Estimates of the current market size and revenue forecasts, accompanied by a corresponding market share analysis based on based on solution, sequencing services and platforms, deployment type, application, end-use, and region
• Facts and figures pertaining to the market dynamics, technological advances, regulations, prospects, and the impact of macroeconomic variables
• Insights derived from Porter's Five Forces model, as well as global supply chain analyses
• Review of key granted and published patents
• Analysis of the industry structure, including companies' shares and global rankings, strategic initiatives, M&A activity and a venture funding outlook
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
• Company profiles of major players within the industry, including Illumina Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., and PacBio

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of the Report
• Market Summary
• Market Growth Factors
• Emerging Technologies
• Segmental Analysis
• Regional Analysis
• Conclusion

Chapter 2 Market Overview

• Introduction
• Current and Future Market Overview
• Technology Background
• Biological Data Sources
• Bioinformatics in Systems Biology
• Bioinformatics in Precision Medicine
• Bioinformatics in Drug Development
• Next-Generation Sequencing
• Bioinformatics in Metagenomics
• Bioinformatics in Database Management Systems
• PESTEL Analysis
• Impact of U.S. Tariff Laws on the Global Bioinformatics Market
• Porter's Five Forces Analysis
• Bargaining Power of Buyers: Moderate to High
• Bargaining Power of Suppliers: Moderate to High
• Threat of Substitute: Moderate
• Threat of New Entrants: Moderate
• Industry Rivalry: High
• Supply Chain Analysis
• Upstream: Data Generation and Raw Inputs
• Technology Infrastructure and Platform Development
• Data Processing, Analysis, and Interpretation
• Midstream Integration and Validation
• Downstream: Commercialization and End Users
• Support Services and Ecosystem Partners
• Key Supply Chain Risks and Constraints
• Supply Chain Optimization Trends
• Value Chain Analysis
• Inbound Activities: Data and Input Acquisition
• Operations: Platform and Algorithm Development
• Data Processing and Analytical Services
• Integration, Validation, and Interpretation
• Marketing, Sales, and Commercialization
• Service, Support, and Continuous Improvement

Chapter 3 Market Dynamics

• Overview
• Market Drivers
• Exponential Growth in Biological and Genomic Data
• Expansion of Personalized and Precision Medicine
• Integration of AI, Machine Learning, and Advanced Analytics
• Cloud Computing and Scalable Platforms
• Growing Demand for Drug Discovery and Development Tools
• Market Restraints
• Data Privacy and Security Concerns
• Issues Regarding Modeling Systems
• High Costs of Implementation and Maintenance
• Market Opportunities
• Market Expansion into Emerging Countries
• Growth in Next-Generation Sequencing (NGS) and High-Throughput Analysis

Chapter 4 Regulatory Landscape

• Overview
• Regulatory Frameworks, by Select Country/Region
• U.S.
• Europe
• Asia-Pacific
• Rest of the World

Chapter 5 Emerging Technologies and New Developments

• Emerging Technologies/Trends
• Artificial Intelligence (AI) and Machine Learning (ML) Integration
• Cloud Computing and Big Data Infrastructure
• High-Throughput and Advanced Sequencing Technologies
• Multi-Omics and Single-Cell Analytics
• Gene Editing Informatics
• Spatial Transcriptomics and Imaging Integration

Chapter 6 Market Segmentation Analysis

• Segmentation Breakdown
• Market Breakdown, by Solution
• Key Takeaways
• Hardware
• Software
• Services
• Market Breakdown, by Sequencing Services and Platforms
• Key Takeaways
• Sequencing Services
• Sequencing Platforms
• Market Breakdown, by Deployment
• Key Takeaways
• On-Premises
• Cloud-Based
• Market Breakdown, by Application
• Key Takeaways
• Genomics
• Proteomics
• Transcriptomics
• Pharmacogenomics
• Metabolomics
• Cheminformatics
• Metagenomics
• Others
• Market Breakdown, by End User
• Key Takeaways
• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Others
• Geographic Breakdown
• Market Breakdown, by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

Chapter 7 Competitive Intelligence

• Key Takeaways
• Top Companies Ranking, 2024
• Strategic Analysis

Chapter 8 Appendix

• Methodology
• Abbreviations
• References
• Company Profiles
• AGILENT TECHNOLOGIES INC.
• BIO-RAD LABORATORIES INC.
• DASSAULT SYSTEMES
• DNASTAR
• EXCELRA
• ILLUMINA INC.
• MACVECTOR INC.
• MOLECULAR NETWORKS GMBH
• OCIMUM BIOSOLUTIONS
• PACBIO
• QLUCORE AB
• REAL TIME GENOMICS
• REVVITY
• SIEMENS HEALTHINEERS AG
• THERMO FISHER SCIENTIFIC INC.
• Emerging Start-Ups

List of Tables

• Summary Table : Global Market for Bioinformatics, by Region, Through 2030
• Table 1 : Bioinformatics Tools Used for Metagenomics Analysis
• Table 2 : Asia-Pacific Bioinformatics Market: Regulatory Landscape
• Table 3 : RoW Bioinformatics Market: Regulatory Landscape
• Table 4 : Global Market for Bioinformatics, by Solution, Through 2030
• Table 5 : Global Market for Bioinformatics Hardware, by Type, Through 2030
• Table 6 : Global Market for Bioinformatics Hardware, by Region, Through 2030
• Table 7 : High-Performance Computing Architectures: Advantages and Drawbacks
• Table 8 : Highest Performance Supercomputers, 2025
• Table 9 : List of SaaS Products for Data Analysis in Bioinformatics
• Table 10 : Global Market for High-Performance Computing Clusters in Bioinformatics Hardware, by Region, Through 2030
• Table 11 : Global Market for Storage Systems in Bioinformatics Hardware, by Region, Through 2030
• Table 12 : Global Market for Bioinformatics Servers in Bioinformatics Hardware, by Region, Through 2030
• Table 13 : Global Market for Bioinformatics Appliances in Bioinformatics Hardware, by Region, Through 2030
• Table 14 : Global Market for Bioinformatics in Other Hardware Solutions, by Region, Through 2030
• Table 15 : Global Market for Bioinformatics Software, by Region, Through 2030
• Table 16 : Global Market for Bioinformatics Services, by Region, Through 2030
• Table 17 : Global Market for Bioinformatics, by Sequencing Services and Platforms, Through 2030
• Table 18 : List of Bioinformatics Sequence Analysis Software
• Table 19 : Global Market for Bioinformatics Sequencing Services, by Region, Through 2030
• Table 20 : List of Bioinformatics Sequence Alignment Platforms
• Table 21 : Global Market for Bioinformatics Sequencing Platforms, by Region, Through 2030
• Table 22 : Global Market for Bioinformatics, by Deployment, Through 2030
• Table 23 : Global Market for Bioinformatics On-Premises Deployment, by Region, Through 2030
• Table 24 : Cloud-Based Bioinformatics Tools
• Table 25 : Global Market for Bioinformatics Cloud-Based Deployment, by Region, Through 2030
• Table 26 : Global Market for Bioinformatics, by Application, Through 2030
• Table 27 : Global Market for Bioinformatics in Genomics Applications, by Region, Through 2030
• Table 28 : Global Market for Bioinformatics in Proteomics Applications, by Region, Through 2030
• Table 29 : Global Market for Bioinformatics in Transcriptomics Applications, by Region, Through 2030
• Table 30 : Pharmacogenomic Biomarkers in Drug Labeling
• Table 31 : Bioinformatics Tools and Databases Used in Pharmacogenomics
• Table 32 : Bioinformatics Tools for Pharmacogenomic Studies
• Table 33 : Global Market for Bioinformatics in Pharmacogenomics Applications, by Region, Through 2030
• Table 34 : Commercially Available Metabolomics Software
• Table 35 : Open Access Tools for Complex Liquid Chromatography-Mass SpectrometryData Analysis
• Table 36 : Global Market for Bioinformatics in Metabolomics Applications, by Region, Through 2030
• Table 37 : Cheminformatics Software Solutions for Drug R&D
• Table 38 : Global Market for Bioinformatics in Cheminformatics Applications, by Region, Through 2030
• Table 39 : Global Market for Bioinformatics in Metagenomics Applications, by Region, Through 2030
• Table 40 : Global Market for Bioinformatics in Other Applications, by Region, Through 2030
• Table 41 : Global Market for Bioinformatics, by End User, Through 2030
• Table 42 : Global Market for Bioinformatics for Pharmaceutical and Biotechnology Companies, by Region, Through 2030
• Table 43 : Global Market for Bioinformatics for Academic and Research Institutes, by Region, Through 2030
• Table 44 : Global Market for Bioinformatics for Other End Users, by Region, Through 2030
• Table 45 : Global Market for Bioinformatics, by Region, Through 2030
• Table 46 : Number of Grants, by Type of Cancer, October 2025
• Table 47 : North American Market for Bioinformatics, by Solution, Through 2030
• Table 48 : North American Market for Bioinformatics, by Hardware Type, Through 2030
• Table 49 : North American Market for Bioinformatics, by Sequencing Services and Platforms, Through 2030
• Table 50 : North American Market for Bioinformatics, by Deployment, Through 2030
• Table 51 : North American Market for Bioinformatics, by Application, Through 2030
• Table 52 : North American Market for Bioinformatics, by End User, Through 2030
• Table 53 : North American Market for Bioinformatics, by Country, Through 2030
• Table 54 : Leading Bioinformatics Companies in the U.S.
• Table 55 : Projected Cancer-Related Deaths in Males in Canada, by Cancer Type, 2025
• Table 56 : Projected Cancer-Related Deaths in Females in Canada, by Cancer Type, 2025
• Table 57 : Leading European Bioinformatics Companies
• Table 58 : European Market for Bioinformatics, by Solution, Through 2030
• Table 59 : European Market for Bioinformatics, by Hardware Type, Through 2030
• Table 60 : European Market for Bioinformatics, by Sequencing Services and Platforms, Through 2030
• Table 61 : European Market for Bioinformatics, by Deployment, Through 2030
• Table 62 : European Market for Bioinformatics, by Application, Through 2030
• Table 63 : European Market for Bioinformatics, by End User, Through 2030
• Table 64 : European Market for Bioinformatics, by Country, Through 2030
• Table 65 : Asia-Pacific Market for Bioinformatics, by Solution, Through 2030
• Table 66 : Asia-Pacific Market for Bioinformatics, by Hardware Type, Through 2030
• Table 67 : Asia-Pacific Market for Bioinformatics, by Sequencing Services and Platforms, Through 2030
• Table 68 : Asia-Pacific Market for Bioinformatics, by Deployment, Through 2030
• Table 69 : Asia-Pacific Market for Bioinformatics, by Application, Through 2030
• Table 70 : Asia-Pacific Market for Bioinformatics, by End User, Through 2030
• Table 71 : Asia-Pacific Market for Bioinformatics, by Country, Through 2030
• Table 72 : RoW Market for Bioinformatics, by Solution, Through 2030
• Table 73 : RoW Market for Bioinformatics, by Hardware Type, Through 2030
• Table 74 : RoW Market for Bioinformatics, by Sequencing Services and Platforms, Through 2030
• Table 75 : RoW Market for Bioinformatics, by Deployment, Through 2030
• Table 76 : RoW Market for Bioinformatics, by Application, Through 2030
• Table 77 : RoW Market for Bioinformatics, by End User, Through 2030
• Table 78 : RoW Market for Bioinformatics, by Sub-Region, Through 2030
• Table 79 : Top Companies Ranking, 2024
• Table 80 : Recent Developments in the Global Bioinformatics Market, 2023-2026
• Table 81 : Abbreviations Used in this Report
• Table 82 : Agilent Technologies Inc.: Company Snapshot
• Table 83 : Agilent Technologies Inc.: Financial Performance, FY 2023 and 2024
• Table 84 : Agilent Technologies Inc.: Product Portfolio
• Table 85 : Agilent Technologies Inc.: News/Key Developments, 2023-2025
• Table 86 : Bio-Rad Laboratories Inc.: Company Snapshot
• Table 87 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2023 and 2024
• Table 88 : Bio-Rad Laboratories Inc.: Product Portfolio
• Table 89 : Dassault Systemes: Company Snapshot
• Table 90 : Dassault Systemes: Financial Performance, FY 2023 and 2024
• Table 91 : Dassault Systemes: Product Portfolio
• Table 92 : Dassault Systemes: News/Key Developments, 2024
• Table 93 : DNASTAR: Company Snapshot
• Table 94 : DNASTAR: Product Portfolio
• Table 95 : DNASTAR: News/Key Developments, 2025
• Table 96 : Excelra: Company Snapshot
• Table 97 : Excelra: Product Portfolio
• Table 98 : Illumina Inc.: Company Snapshot
• Table 99 : Illumina Inc.: Financial Performance, FY 2023 and 2024
• Table 100 : Illumina Inc.: Product Portfolio
• Table 101 : Illumina Inc.: News/Key Developments, 2024-2026
• Table 102 : MacVector Inc.: Company Snapshot
• Table 103 : MacVector Inc.: Product Portfolio
• Table 104 : Molecular Networks GmbH: Company Snapshot
• Table 105 : Molecular Networks GmbH: Product Portfolio
• Table 106 : Molecular Networks GmbH: News/Key Developments, 2025
• Table 107 : Ocimum Biosolutions: Company Snapshot
• Table 108 : Ocimum Biosolutions: Product Portfolio
• Table 109 : PacBio: Company Snapshot
• Table 110 : PacBio: Financial Performance, FY 2023 and 2024
• Table 111 : PacBio: Product Portfolio
• Table 112 : PacBio: News/Key Developments, 2025
• Table 113 : Qlucore AB: Company Snapshot
• Table 114 : Qlucore AB: Financial Performance, FY 2023 and 2024
• Table 115 : Qlucore AB: Product Portfolio
• Table 116 : Qlucore AB: News/Key Developments, 2025
• Table 117 : Real Time Genomics: Company Snapshot
• Table 118 : Real Time Genomics: Product Portfolio
• Table 119 : Revvity: Company Snapshot
• Table 120 : Revvity: Financial Performance, FY 2023 and 2024
• Table 121 : Revvity: Product Portfolio
• Table 122 : Siemens Healthineers AG: Company Snapshot
• Table 123 : Siemens Healthineers AG: Financial Performance, FY 2024 and 2025
• Table 124 : Siemens Healthineers AG: Product Portfolio
• Table 125 : Siemens Healthineers AG: News/Key Developments, 2025
• Table 126 : Thermo Fisher Scientific Inc.: Company Snapshot
• Table 127 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
• Table 128 : Thermo Fisher Scientific Inc.: Product Portfolio
• Table 129 : Thermo Fisher Scientific Inc.: News/Key Developments, 2024
• Table 130 : Emerging Startups in the Global Bioinformatics Market

List of Figures

• Summary Figure : Summary Figure: Global Market Share for Bioinformatics, by Region, 2024
• Figure 1 : Bioinformatics Relationship with Omic Technologies
• Figure 2 : Applications of Bioinformatics in Drug Development
• Figure 3 : PESTEL Analysis: Bioinformatics Market
• Figure 4 : Porter's Five Forces Analysis: Bioinformatics Market
• Figure 5 : Supply Chain Analysis: Global Bioinformatics Market
• Figure 6 : Value Chain Analysis: Global Bioinformatics Market
• Figure 7 : Market Dynamics of Bioinformatics
• Figure 8 : Emerging Technologies in the Bioinformatics Market
• Figure 9 : Global Market Share for Bioinformatics, by Solution, 2024
• Figure 10 : Global Market Share for Bioinformatics, by Sequencing Services and Sequencing Platforms, 2024
• Figure 11 : Global Market Share for Bioinformatics, by Deployment, 2024
• Figure 12 : Global Market Share for Bioinformatics, by Application, 2024
• Figure 13 : Global Market Share for Bioinformatics, by End User, 2024
• Figure 14 : Global Market Share for Bioinformatics, by Region, 2024
• Figure 15 : North American Market Share for Bioinformatics, by Country, 2024
• Figure 16 : European Market Share for Bioinformatics, by Country, 2024
• Figure 17 : Asia-Pacific Market Share for Bioinformatics, by Country, 2024
• Figure 18 : RoW Market Share for Bioinformatics, by Sub-Region, 2024
• Figure 19 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2024
• Figure 20 : Agilent Technologies Inc.: Revenue Share, by Region/Country, FY 2024
• Figure 21 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2024
• Figure 22 : Bio-Rad Laboratories Inc.: Revenue Share, by Region/Country, FY 2024
• Figure 23 : Dassault Systemes: Revenue Share, by Business Unit, FY 2024
• Figure 24 : Dassault Systemes: Revenue Share, by Region/Country, FY 2024
• Figure 25 : Illumina Inc.: Revenue Share, by Business Unit, FY 2024
• Figure 26 : Illumina Inc.: Revenue Share, by Country/Region, FY 2024
• Figure 27 : PacBio: Revenue Share, by Region/Country, FY 2024
• Figure 28 : Revvity: Revenue Share, by Business Unit, FY 2024
• Figure 29 : Revvity: Revenue Share, by Region/Country, FY 2024
• Figure 30 : Siemens Healthineers AG: Revenue Share, by Business Unit, FY 2025
• Figure 31 : Siemens Healthineers AG: Revenue Share, by Country/Region, FY 2025
• Figure 32 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2024
• Figure 33 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2024